Immunovant, Inc. Common Stock IMVT
$41.82
+0.00%
at last close
Analyst Consensus
- Consensus Rating
- Buy (6 Buy · 2 Hold · 0 Sell)
- Average Price Target
- $46.00
- Implied Upside
- +10.0%
- Price Target Range
- $30.00 – $62.00
- Analysts (12 mo)
- 8
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-04 | JP MorganBrian Cheng |
Maintains | Overweight | $47 → $50 |
| 2026-06-30 | CitigroupSamantha Semenkow |
Maintains | Buy | $57 → $61 |
| 2026-05-26 | GuggenheimYatin Suneja |
Maintains | Buy | $44 → $62 |
| 2026-05-22 | Truist SecuritiesDanielle Brill |
Maintains | Hold | $23 → $30 |
| 2026-05-21 | B of A SecuritiesJason Gerberry |
Maintains | Buy | $32 → $43 |
| 2026-05-21 | HC Wainwright & Co.Douglas Tsao |
Maintains | Buy | $35 → $40 |
| 2026-04-15 | Goldman SachsCorinne Johnson |
Maintains | Neutral | $29 → $32 |
| 2026-02-10 | HC Wainwright & Co.Douglas Tsao |
Reiterates | Buy | $35 |
| 2026-02-09 | GuggenheimYatin Suneja |
Maintains | Buy | $41 → $44 |
| 2026-01-08 | Truist SecuritiesDanielle Brill |
Maintains | Hold | $16 → $22 |
| 2026-01-06 | Wolfe ResearchAndy Chen |
Upgrades | Peer perform → Outperform | $50 |
| 2025-12-15 | Goldman SachsCorinne Johnson |
Maintains | Neutral | $18 → $28 |
| 2025-10-14 | Truist SecuritiesDanielle Brill |
Initiates coverage on | Hold | $16 |
| 2025-09-30 | JP MorganBrian Cheng |
Maintains | Overweight | $37 → $33 |
| 2025-09-04 | HC Wainwright & Co.Douglas Tsao |
Reiterates | Buy | $35 |
| 2025-08-12 | JP MorganBrian Cheng |
Maintains | Overweight | $40 → $37 |
| 2025-08-12 | B of A SecuritiesJason Gerberry |
Maintains | Buy | $33 → $30 |
| 2025-07-28 | UBSAshwani Verma |
Maintains | Neutral | $17 → $18 |
| 2025-04-22 | UBSColin Bristow |
Downgrades | Buy → Neutral | $38 → $17 |
| 2025-03-20 | GuggenheimYatin Suneja |
Reiterates | Buy | — |
| 2025-03-20 | B of A SecuritiesJason Gerberry |
Maintains | Buy | $38 → $33 |
| 2025-03-19 | HC Wainwright & Co.Douglas Tsao |
Reiterates | Buy | $51 |
| 2025-03-10 | GuggenheimYatin Suneja |
Reiterates | Buy | — |
| 2025-02-10 | GuggenheimYatin Suneja |
Maintains | Buy | $46 → $44 |
| 2025-02-10 | HC Wainwright & Co.Douglas Tsao |
Reiterates | Buy | $51 |
| 2025-02-07 | HC Wainwright & Co.Douglas Tsao |
Reiterates | Buy | $51 |
| 2025-01-15 | B of A SecuritiesJason Gerberry |
Maintains | Buy | $48 → $45 |
| 2025-01-03 | Wolfe ResearchAndy Chen |
Downgrades | Outperform → Peer perform | — |
| 2024-12-19 | Wells FargoDerek Archila |
Maintains | Overweight | $47 → $45 |
| 2024-11-08 | HC Wainwright & Co.Douglas Tsao |
Reiterates | Buy | $51 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $41.82
- Market Cap
- $8.64 billion
- 52-Week Range
- $14.32 – $42.92
- Average Volume
- 1.04 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.